.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Covington
Harvard Business School
McKinsey
US Army
Chubb
Express Scripts
Novartis
Merck
Moodys

Generated: November 24, 2017

DrugPatentWatch Database Preview

Sage Prods Company Profile

« Back to Dashboard

What is the competitive landscape for SAGE PRODS, and when can generic versions of SAGE PRODS drugs launch?

SAGE PRODS has one approved drug.

There are five US patents protecting SAGE PRODS drugs.

There are three patent family members on SAGE PRODS drugs in one country.

Summary for Sage Prods

International Patents:3
US Patents:5
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sage Prods
CHLORHEXIDINE GLUCONATE
chlorhexidine gluconate
CLOTH;TOPICAL021669-001Apr 25, 2005OTCYesYes► Subscribe► SubscribeY ► Subscribe
Sage Prods
CHLORHEXIDINE GLUCONATE
chlorhexidine gluconate
CLOTH;TOPICAL021669-001Apr 25, 2005OTCYesYes► Subscribe► SubscribeY ► Subscribe
Sage Prods
CHLORHEXIDINE GLUCONATE
chlorhexidine gluconate
CLOTH;TOPICAL021669-001Apr 25, 2005OTCYesYes► Subscribe► SubscribeY ► Subscribe
Sage Prods
CHLORHEXIDINE GLUCONATE
chlorhexidine gluconate
CLOTH;TOPICAL021669-001Apr 25, 2005OTCYesYes► Subscribe► SubscribeY ► Subscribe
Sage Prods
CHLORHEXIDINE GLUCONATE
chlorhexidine gluconate
CLOTH;TOPICAL021669-001Apr 25, 2005OTCYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Sage Prods

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,221,365Disinfectant delivery system, and method of providing alcohol-free disinfection► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Sage Prods Drugs

Country Document Number Estimated Expiration
Canada2467155► Subscribe
Canada2551688► Subscribe
Canada2467150► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Federal Trade Commission
McKinsey
McKesson
Fish and Richardson
Boehringer Ingelheim
Dow
Medtronic
Novartis
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot